2016-03-07T00:00:00.000-05:00
analysts,0.504652
negative EPS growth,-0.241379
reports earnings,-0.30474
S&P500,-0.470235
Wall Street,-0.241379
cancer patients,-0.385214
latest news,0.504652
email newsletter,0.580274
clinical-stage biopharmaceutical company,0.28765
Inc.,0.28765
commercialization,-0.385214
shares,-0.258595
Ratings Via Email,0.398382
share,0.22321
concise daily summary,0.504652
stock,-0.457179
treatment resistance,-0.385214
hands,-0.258595
negative earnings,-0.772623
trading session,-0.457179
email address,0.504652
Receive News,0.398382
new therapies,-0.385214
average,-0.258595
Firm,-0.385214
